"All or nothing" push on ATMP abandoned by European Parliament
This article was originally published in Clinica
Miroslav Mikolasik, rapporteur at the European Parliament for the European Commission's proposed Advanced Therapy Medicinal Products Regulation, has terminated discussions between the European Commission, the European Parliament and the European Council aimed at reaching agreement on the text in a first reading.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.